biote Corp. (ticker: BTMD) is an NASDAQ-listed medicinal chemicals & botanical products company. DredgeCap's structured extraction of BTMD's SEC filings surfaces 8 active risk signals, including 5 late-filing signals, 2 delisting/deregistration signals, and 1 auditor-change signal. BTMD reported $44.94M in revenue and $2.28M for the period ending 2026-03-31, with operating cash flow of $3.90M. Cash and equivalents stood at $5.32M (down 87.2% year-over-year). Total assets of $89.03M are exceeded by total liabilities of $136.99M. Each signal on this page is sourced verbatim from the underlying SEC filing. Use the tabs above to drill into auditor history, going-concern citations, dilution mechanics, cash runway, and the full risk-flag inventory.
BTMD SEC Filings
Full cached SEC EDGAR filing history for BTMD, grouped by form type and sorted newest-first within each group. 0 filings across 0 form types.
Filings sourced verbatim from SEC EDGAR submissions metadata. “Structured” links route to DredgeCap's per-filing renderer (XBRL-backed financials + cited highlights) when available; the EDGAR link always points to the canonical accession index on sec.gov.